1. Home
  2. TNGX vs CARE Comparison

TNGX vs CARE Comparison

Compare TNGX & CARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • CARE
  • Stock Information
  • Founded
  • TNGX 2014
  • CARE 1974
  • Country
  • TNGX United States
  • CARE United States
  • Employees
  • TNGX N/A
  • CARE N/A
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • CARE Major Banks
  • Sector
  • TNGX Health Care
  • CARE Finance
  • Exchange
  • TNGX Nasdaq
  • CARE Nasdaq
  • Market Cap
  • TNGX 317.4M
  • CARE 330.3M
  • IPO Year
  • TNGX N/A
  • CARE N/A
  • Fundamental
  • Price
  • TNGX $1.14
  • CARE $15.62
  • Analyst Decision
  • TNGX Strong Buy
  • CARE Buy
  • Analyst Count
  • TNGX 7
  • CARE 2
  • Target Price
  • TNGX $12.33
  • CARE $21.50
  • AVG Volume (30 Days)
  • TNGX 532.3K
  • CARE 58.9K
  • Earning Date
  • TNGX 05-12-2025
  • CARE 04-24-2025
  • Dividend Yield
  • TNGX N/A
  • CARE N/A
  • EPS Growth
  • TNGX N/A
  • CARE 112.13
  • EPS
  • TNGX N/A
  • CARE 1.20
  • Revenue
  • TNGX $42,069,000.00
  • CARE $146,558,000.00
  • Revenue This Year
  • TNGX N/A
  • CARE $12.21
  • Revenue Next Year
  • TNGX N/A
  • CARE $12.73
  • P/E Ratio
  • TNGX N/A
  • CARE $13.17
  • Revenue Growth
  • TNGX 15.17
  • CARE 18.52
  • 52 Week Low
  • TNGX $1.11
  • CARE $11.96
  • 52 Week High
  • TNGX $12.02
  • CARE $20.40
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 36.06
  • CARE 52.43
  • Support Level
  • TNGX $1.03
  • CARE $15.37
  • Resistance Level
  • TNGX $1.56
  • CARE $15.79
  • Average True Range (ATR)
  • TNGX 0.15
  • CARE 0.36
  • MACD
  • TNGX -0.01
  • CARE 0.11
  • Stochastic Oscillator
  • TNGX 17.74
  • CARE 64.17

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.

About CARE Carter Bankshares Inc.

Carter Bankshares Inc is a bank holding company that conducts its business solely through the bank. The Bank earns revenue from interest on loans and securities and fees charged for financial services provided to customers. It offers a full range of deposit services including Lifetime Free Checking, interest checking accounts, savings accounts, retirement accounts and other deposit accounts of various types, ranging from money market accounts to longer-term CDs. The Bank offers a full range of commercial and consumer loans. The Bank also originates and holds fixed and variable-rate mortgage loans and offers home equity lines of credit to its customers.

Share on Social Networks: